Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Aug 15, 2026
iShares Russell 2000 ETF (IWM) Delivers +3.2% Gain Over 30 Days

iShares Russell 2000 ETF (IWM) Delivers +3.2% Gain Over 30 Days

Key Takeaways

  • The iShares Russell 2000 ETF (IWM) tracks the Russell 2000 Index, spanning roughly 2,000 U.S. small-capitalization stocks.
  • As of mid-August 2026, IWM traded near $305, up about 3.2% over the latest 30-calendar-day window and approximately 7.3% over the trailing quarter.
  • Healthcare and financials each represent close to 20% of the portfolio, followed by industrials and information technology.
  • Top holdings are highly diversified, with names such as Hut 8 (HUT), Moog (MOG.A), and BrightSpring Health Services (BTSG) each below 0.5% of assets.
  • The fund's passive structure, 0.19% net expense ratio, and rate-sensitive small-cap composition make interest-rate expectations a central performance driver.

Understanding the iShares Russell 2000 ETF (IWM)

The iShares Russell 2000 ETF is a passively managed exchange-traded fund sponsored by BlackRock. It seeks to track the investment results of the Russell 2000 Index, which measures the small-capitalization segment of the U.S. equity market. Launched in 2000, IWM is one of the most heavily traded small-cap ETFs, with assets under management near $80 billion and roughly 1,970 individual holdings as of mid-2026. I also checked this using Tickeron’s AI Screener to see how the fund compares to other small-cap vehicles.

Individual position sizes are small. The largest holdings as of mid-2026 included Moog (MOG.A), Hut 8 (HUT), BrightSpring Health Services (BTSG), Cytokinetics (CYTK), UMB Financial (UMBF), and Viasat (VSAT); the top 10 names accounted for roughly 3.5% of the portfolio. This diversification limits single-stock risk while making the fund a broad expression of small-cap market beta.

By sector, healthcare and financials each represented approximately 20% of the fund, followed by industrials around 14%, information technology around 13%, consumer discretionary near 9%, and smaller allocations to energy, real estate, materials, utilities, and communication services. Because IWM is a market-cap-weighted index fund, its sector mix shifts with the Russell 2000's evolving composition rather than active manager decisions. The net expense ratio is 0.19%.

The Broader Context for Small Caps

The environment around IWM is shaped by the intersection of monetary policy, credit conditions, and the U.S. growth outlook. Small-cap companies tend to carry a larger share of floating-rate or shorter-maturity debt than large-cap firms, so changes in interest-rate expectations feed quickly into their financing costs and earnings estimates. Financials—especially regional banks—are directly exposed to lending margins and credit quality, while healthcare and biotechnology names depend on capital-raising conditions and regulatory decisions.

The Russell 2000's sector composition also differs meaningfully from large-cap benchmarks. It carries a smaller weight in mega-cap technology and a larger combined weight in financials and healthcare. As a result, small-cap ETF performance is frequently tied to domestic economic data, bank lending trends, healthcare funding, and mergers and acquisitions (M&A) activity. In 2026, investor attention has centered on the path of Federal Reserve policy, inflation trends, labor-market resilience, and whether earnings strength can broaden beyond mega-cap technology companies.

Recent Performance Trends

Over the 30-calendar-day window through mid-August 2026, IWM advanced about 3.2%, moving from roughly $295.77 to $305.09. The move was not linear: the fund consolidated through much of July, slipped to the lower end of its recent range near $288, and then recovered in August to trade near the top of its 52-week range. Over the trailing three months, the fund rose approximately 7.3%.

This pattern reflects a gradual, range-bound grind higher rather than a sharp, momentum-driven breakout. The fund's heavy weighting in financials and healthcare kept rate and credit themes central to returns, while its extremely diversified holdings meant no single stock drove the advance. Instead, index breadth and sector-level moves mattered more than the performance of any individual top holding.

Factors to Watch Going Forward

The most important factors for IWM in 2026 are likely to remain interest-rate expectations, inflation trends, and the trajectory of U.S. economic growth. Because financials are a large allocation, bank lending margins, deposit costs, and credit quality will matter. In healthcare, biotech financing conditions, drug-pricing policy, and M&A activity are recurring variables. Investors should also monitor earnings revisions across small-cap industrials and consumer discretionary names, which are sensitive to domestic demand.

On the flow side, sustained demand for passive small-cap ETFs can support the asset class, while outflows or a return to narrow mega-cap leadership could act as headwinds. A slower-than-expected decline in inflation or a reacceleration in credit stress would represent downside risks, while broader earnings participation and easing financing conditions would be supportive. No single theme is likely to dominate; instead, the balance between rate policy, credit conditions, and earnings breadth will shape the fund's environment.

Enhancing ETF Research with AI Tools

In my own process, I turn to Tickeron’s AI Screener when I want to quickly compare an ETF like this one against peers on momentum, valuation, and volatility metrics. It helps surface relevant patterns without manually sifting through dozens of screens, which keeps the focus on the factors that matter most for small-cap exposure.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations
Related Ticker: IWM

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


IWM sees MACD Histogram crosses below signal line

IWM saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on August 20, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 44 instances where the indicator turned negative. In of the 44 cases the stock moved lower in the days that followed. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on August 20, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on IWM as a result. In of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

IWM moved below its 50-day moving average on August 28, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for IWM crossed bearishly below the 50-day moving average on September 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IWM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 53 cases where IWM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IWM advanced for three days, in of 320 cases, the price rose further within the following month. The odds of a continued upward trend are .

IWM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Notable companies

The most notable companies in this group are Bloom Energy Corp (NYSE:BE), Guardant Health (NASDAQ:GH), Arrowhead Pharmaceuticals (NASDAQ:ARWR), SSR Mining (NASDAQ:SSRM), Lumen Technologies (NYSE:LUMN), Transocean Ltd (NYSE:RIG), Abercrombie & Fitch Co (NYSE:ANF), Valaris Limited (NYSE:VAL), California Resources Corp (NYSE:CRC), CommScope Holding Company (NASDAQ:COMM).

Industry description

The investment seeks to track the investment results of the Russell 2000® Index, which measures the performance of the small-capitalization sector of the U.S. equity market. The underlying index is a float-adjusted capitalization-weighted index of equity securities issued by the approximately 1,933 smallest issuers in the Russell 3000 Index. The fund may use derivatives to gain or reduce exposure to the components of the underlying index or exposure to one or more market risk factors associated with such components.

Market Cap

The average market capitalization across the iShares Russell 2000 ETF ETF is 2.65B. The market cap for tickers in the group ranges from 455.89K to 76.13B. BE holds the highest valuation in this group at 76.13B. The lowest valued company is ZSPC at 455.89K.

High and low price notable news

The average weekly price growth across all stocks in the iShares Russell 2000 ETF ETF was 43%. For the same ETF, the average monthly price growth was 156%, and the average quarterly price growth was 7,350%. CHPT experienced the highest price growth at 72%, while CRMT experienced the biggest fall at -34%.

Volume

The average weekly volume growth across all stocks in the iShares Russell 2000 ETF ETF was -6%. For the same stocks of the ETF, the average monthly volume growth was -13% and the average quarterly volume growth was -32%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 56
Price Growth Rating: 51
SMR Rating: 71
Profit Risk Rating: 76
Seasonality Score: -16 (-100 ... +100)
View a ticker or compare two or three
IWM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category SmallBlend

Profile
Details
Category
Small Blend
Address
iShares Trust400 Howard StreetSan Francisco
Phone
415-670-2000
Web
www.ishares.com
Interact to see
Advertisement
HIMS shares surged approximately +43.85% in premarket trading on Monday, March 9, 2026, rising from a prior close of $15.74 to around $22.80. Primary catalyst: Novo Nordisk officially ended its patent infringement lawsuit against Hims & Hers and announced a landmark partnership to distribute branded Wegovy through the Hims platform at $599/month.
XENE shares surged approximately +45.93% in premarket trading on March 9, 2026, one of the largest single-session moves in the company's history. The primary catalyst: Xenon announced positive topline Phase 3 X-TOLE2 results for its lead drug candidate azetukalner in focal onset seizures (FOS), meeting the primary endpoint with overwhelming statistical significance.
Shares of OLMA dropped approximately 41% in Monday's session, one of the steepest single-day declines in the company's history. The primary catalyst was Roche's Phase 3 persevERA trial failure — a late-stage study of giredestrant, a closely competing selective estrogen receptor degrader (SERD), which missed its primary endpoint of statistically significant improvement in progression-free survival.
RLMD shares surged approximately +40% at the open on March 9, 2026, rising from a prior close of $4.45 to approximately $6.23, driven by a major clinical trial readout. The primary catalyst was the announcement of 12-month interim data from the Phase 2 trial of NDV-01, Relmada's lead oncology candidate, in patients with high-risk non-muscle invasive bladder cancer (NMIBC) — results that significantly exceeded historical benchmarks.
CRCL surged +8.66% on Monday, March 9, 2026, rising from a prior close of $101.94 to trade at $110.77 intraday. The primary catalyst is a landmark stablecoin milestone: Circle's USDC overtook Tether as the dominant stablecoin by transfer volume, accounting for approximately 70% of all stablecoin transfer activity as total stablecoin transfers hit $1.8 trillion in February.
Carnival Corporation (CCL) shares fell approximately -7.60% in Monday's session, dropping from a Friday close of $25.79 to around $23.83. The primary catalyst is a broad market sell-off driven by intensifying recession fears, with the S&P 500 and consumer discretionary names bearing the brunt of the pressure.
Shares of Bloom Energy (BE) are surging approximately +10.30% in Monday's session, rebounding sharply from a steep -15.50% selloff on Friday, March 6, 2026. Friday's decline was triggered by an Oracle-OpenAI data center project update that spooked energy infrastructure investors; Monday's move reflects aggressive dip-buying and a sentiment reset.
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.
Shares of ARQ plunged approximately 27.50% in premarket trading on March 10, 2026, from a prior close of $3.20 to roughly $2.32. The primary catalyst was a deeply disappointing Q4 2025 earnings report, which revealed a net loss of $50.0 million for the quarter versus a net loss of $1.3 million in Q4 2024.
RAIL shares fell approximately 15% in premarket trading on March 10, 2026, following a steep after-hours reaction to disappointing Q4 2025 earnings results released after the close on March 9. The primary catalyst was a significant revenue miss: Q4 revenue came in at $125.6 million, well below consensus estimates near $144–$160 million, representing an 8.8% year-over-year decline.
ZVRA shares surged approximately +17.86% on March 10, 2026, driven by a blockbuster Q4 and full-year 2025 earnings report released before the market open. Primary catalyst: Q4 2025 EPS of $0.19 crushed the consensus estimate of $0.05 — a 280% beat — while revenue of $34.1 million exceeded forecasts by 21.57%.
LITE surged +14.73% on Monday, March 9, 2026, closing at $640.69 versus a prior close of $558.44 on March 6. The primary catalyst was the landmark $2 billion strategic investment by NVIDIA announced March 2, with the market continuing to price in its full implications following a brief post-announcement pullback.
Shares of BNTX fell approximately 22% on Tuesday, March 10, 2026, following a dual shock of disappointing full-year guidance and a surprise leadership upheaval. The primary catalyst was BioNTech's Q4 2025 earnings report, which included a 2026 revenue outlook of €2.0–€2.3 billion — well below analyst consensus and signaling continued pressure from declining COVID-19 vaccine demand.
CNC shares fell approximately 10% during Tuesday's session, extending a prolonged selloff in the managed care sector. The primary catalyst is intensifying investor concern over federal Medicaid and ACA funding cuts tied to the "One Big Beautiful Bill Act" (OBBBA), which threatens to shrink the government-sponsored insurance pools that Centene depends on for the majority of its revenue.
Technology recently peaked near 35% of the S&P 500 and has slipped over the last year, while Energy plus Materials remain near historically low combined weight at roughly 6%, which suggests the gap is still unusually wide.
Average daily equity purchases by retail investors on S&P 500 down days in 2026 are at the highest level on record, running about 100% above the peak intensity seen during the 2021 meme‑stock boom.
Over the past two weeks, PLTR has climbed from roughly the high‑130s to the mid‑150s, a gain of about 12–14%, with a series of strong up days between March 2 and March 6.
AVAV shares dropped approximately 10% in premarket trading on March 11, 2026, following a disappointing Q3 fiscal 2026 earnings report released after the prior session's close. Q3 revenue of $408.0 million came in far below analyst consensus of approximately $475–$488 million, representing a massive top-line miss.
KOS shares are down approximately 20% in premarket trading on March 11, 2026, having shed roughly 20.31% across the last two sessions (Tuesday close and premarket Wednesday). The primary catalyst is Kosmos Energy's announcement of a massive $185.25 million public equity offering priced at $1.90 per share — a steep discount to recent trading levels.